Literature DB >> 6186857

Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the scavenging of free radicals.

M L Hess, E Okabe, J Poland, M Warner, J R Stewart, L J Greenfield.   

Abstract

Glucose, insulin, potassium (GIK: 300 g glucose + 50 U insulin + 80 mEq KC1/L) was administered to anesthetized dogs as a 30-ml bolus followed by 1.5 ml/kg/h for 2 h. Five populations were studied: control (C, n = 6); 60 min hypothermic arrest both without (I, n = 6) and with pretreatment (I + GIK, n = 6); 60 min hypothermic arrest followed by reperfusion without (R, n = 6) and with pretreatment (R + GIK, n = 6). Glycogen content declined during the ischemic and reperfusion periods whether or not GIK pretreatment was utilized. Glycogen values did not differ significantly among the four groups. GIK pretreatment significantly protected sarcoplasmic reticulum (SR) calcium uptake rates. SR Ca2+ + Mg2+ adenosine triphosphatase (ATPase) activity was unaffected in the I group, depressed in the R group, but protected by GIK pretreatment. Myofibrillar pCa-ATPase activity was significantly depressed in the I group and unaffected by GIK pretreatment. In the R + GIK group, myofibrillar pCa-ATPase activity was identical to controls at all calcium concentrations except for Vmax. In vitro, generation of the superoxide anion by a xanthine-xanthine oxidase system at pH 7.0 significantly depressed both SR calcium uptake and ATPase activity, and this depression was partially reversible by glucose. Generation of the hydroxyl free radical and pH 6.4 significantly depressed calcium uptake but not ATPase activity, and this depression was reversible with glucose + superoxide dismutase. GIK pretreatment exerts a protective effect on the excitation-contraction coupling system during hypothermic global ischemia and reperfusion. Glycogen augmentation after short-term GIK infusion was not significantly different. It is hypothesized that an additional mechanism by which GIK may protect subcellular function is by serving as a scavenger of free radicals generated during the ischemic/reperfusion process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186857     DOI: 10.1097/00005344-198301000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Trimetazidine protects the human red blood cell against oxygen free radical damage.

Authors:  I Maridonneau-Parini; C Harpey
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

Authors:  E M Runnman; S T Lamp; J N Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 3.  Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.

Authors:  L M King; L H Opie
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

4.  Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium.

Authors:  J L Zweier; B K Rayburn; J T Flaherty; M L Weisfeldt
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  A model of anoxic preconditioning in the isolated rat cardiac myocyte. Importance of adenosine and insulin.

Authors:  A C Cave; S Adrian; C S Apstein; H S Silverman
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

6.  Effects of antioxidant therapy in experimentally induced heart infarcts.

Authors:  B Török; E Röth; V Bär; Z Pollák
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

7.  Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells.

Authors:  I Maridonneau-Parini; C Harpey
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 8.  Novel adjunctive treatments of myocardial infarction.

Authors:  Michael Rahbek Schmidt; Kasper Pryds; Hans Erik Bøtker
Journal:  World J Cardiol       Date:  2014-06-26

9.  An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution.

Authors:  I W Suranadi; L Demaison; V Chaté; S Peltier; M Richardson; X Leverve
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

10.  Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes.

Authors:  RyungA Kang; Sangbin Han; Kyo Won Lee; Gaab Soo Kim; Soo Joo Choi; Justin S Ko; Sang Hyun Lee; Mi Sook Gwak
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.